top of page

STM961

Stomach cancer tissue array containing 48 cases of paired primary and metastatic tumors (in lymph nodes and other organs) from the same patients.

Specification

Images

Data Sheet

TNM Grading

Downloads

Price

Size

Availability

$475

1 slide

In-Stock

A
B
C
D
E
F
G
H
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg
UNC241A-C02.jpg

TNM Classification : Stomach carcinoma

 

 

T- Primary tumor

TX - Primary tumor cannot be assessed

TO - No evicence of primary tumor

Tis - Carcinoma in situ, intraepithelial tumor without invasion of the lamina propria

T1 - Tumor invades lamina pripria or submucosa

T2 - Tumor invades muscularis propria or subserosa

T3 - Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent

        structures

T4 - Tumor invades adjacent structures

N - Regional lymph nodes

NX - Regional lymph nodes cannot be assessed

NO - No regional lymph node metastasis

N1 - Metastasis in 1 to 6 regional lymph nodes

N2 - metastasis in 7 -15 regional lymph nodes

N3 - metastasis in more than 15 regional lymph nodes

M - Distant metastasis

MX - Distant metastasis cannot be assessed

MO - No distant metastasis

M1 - Distant metastasis

Species

Human

Cases

48

Cores

96

Core Diameter

1.5mm

Core Thickness

4um

Rows

8

Columns

12

Tissue Type

Paraffin

Notes:

All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.

Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.

Recommended Application

For research use only. Designed for comparative IHC or ISH based protein or RNA tissue profiling in paired primary and metastatic tumor tissues from multiple stomach cancer patients.

4X6b.jpg

ARRAY POSITION
IMAGE
SEX
AGE
ANATOMIC SITE
PATHOLOGY
GRADE
STAGE (TNM)
A01
M
52
Stomach
Adenocarcinoma
III
T3N1M0
A02
F
45
Stomach
Adenocarcinoma
III
T3N1M0
A03
F
43
Stomach
Adenocarcinoma
III
T3N1M0
A04
F
44
Stomach
Adenocarcinoma
III
T3N2M0
A05
M
80
Stomach
Adenocarcinoma
I
T4N1M0
A06
M
59
Stomach
Adenocarcinoma
II~III
T3N1M0
A07
M
72
Stomach
Adenocarcinoma
II~III
T3N1M0
A08
M
68
Stomach
Adenocarcinoma
III
T3N1M0
A09
M
68
Stomach
Adenocarcinoma
III
T3N2M0
A10
F
53
Stomach
Adenocarcinoma
III
T3N0M0
A11
F
68
Stomach
Adenocarcinoma
III
T3N1M0
A12
M
80
Stomach
Adenocarcinoma
II~III
T2N1M0
B01
M
52
Lymph node
Lymph node metastasis of A01
B02
F
45
Lymph node
Lymph node metastasis of A02
B03
F
43
Lymph node
Lymph node metastasis of A03
B04
F
44
Lymph node
Lymph node metastasis of A04
B05
M
80
Lymph node
Lymph node metastasis of A05
B06
M
59
Lymph node
Lymph node metastasis of A06
B07
M
72
Lymph node
Lymph node metastasis of A07
B08
M
68
Lymph node
Lymph node metastasis of A08
B09
M
68
Lymph node
Lymph node metastasis of A09
B10
F
53
Lymph node
Lymph node metastasis of A10
B11
F
68
Lymph node
Lymph node metastasis of A11
B12
M
80
Lymph node
Lymph node metastasis of A12
C01
M
54
Stomach
Adenocarcinoma
III
T3N1M0
C02
M
60
Stomach
Adenocarcinoma
III
T2N1M0
C03
M
42
Stomach
Adenocarcinoma
III
T3N2M0
C04
F
59
Stomach
Adenocarcinoma
III
T3N2M0
C05
M
50
Stomach
Adenocarcinoma
II~III
T3N2M0
C06
F
52
Stomach
Adenocarcinoma
III
T3N1M0
C07
F
68
Stomach
Adenocarcinoma
III
T3N2M0
C08
M
63
Stomach
Adenocarcinoma
III
T3N2M0
C09
M
61
Stomach
Adenocarcinoma
II
T3N2M0
C10
M
56
Stomach
Signet ring cell carcinoma
T3N2M0
C11
M
77
Stomach
Undifferentiated carcinoma
III
T3N2M0
C12
F
80
Stomach
Adenocarcinoma
II
T3N2M0
D01
M
54
Lymph node
Lymph node metastasis of C01
D02
M
60
Lymph node
Lymph node metastasis of C02
D03
M
42
Lymph node
Lymph node metastasis of C03
D04
F
59
Lymph node
Lymph node metastasis of C04
D05
M
50
Lymph node
Lymph node metastasis of C05
D06
F
52
Lymph node
Lymph node metastasis of C06
D07
F
68
Lymph node
Lymph node metastasis of C07
D08
M
63
Lymph node
Lymph node metastasis of C08
D09
M
61
Lymph node
Lymph node metastasis of C09
D10
M
56
Lymph node
Lymph node metastasis of C10
D11
M
77
Lymph node
Lymph node metastasis of C11
D12
F
80
Lymph node
Lymph node metastasis of C12
E01
F
38
Stomach
Undifferentiated carcinoma
T2N2M0
E02
F
40
Stomach
Adenocarcinoma
III
T3N1M0
E03
F
45
Stomach
Adenocarcinoma
II
T3N1M0
E04
M
70
Stomach
Adenocarcinoma
II
T3N2M0
E05
M
68
Stomach
Adenocarcinoma
III
T3N2M0
E06
F
33
Stomach
Undifferentiated carcinoma
T3N2M0
E07
M
60
Stomach
Adenocarcinoma
III
T3N2M0
E08
M
45
Stomach
Adenocarcinoma
III
T3N2M0
E09
M
73
Stomach
Adenocarcinoma
II~III
T3N1M0
E10
M
57
Stomach
Signet ring cell carcinoma
T3N2M0
E11
F
31
Stomach
Adenocarcinoma
III
T3N2M0
E12
M
54
Stomach
Adenocarcinoma
III
T3N1M0
F01
F
38
Lymph node
Lymph node metastasis of E01
F02
F
40
Lymph node
Lymph node metastasis of E02
F03
F
45
Lymph node
Lymph node metastasis of E03
F04
M
70
Lymph node
Lymph node metastasis of E04
F05
M
68
Lymph node
Lymph node metastasis of E05
F06
F
33
Lymph node
Lymph node metastasis of E06
F07
M
60
Lymph node
Lymph node metastasis of E07
F08
M
45
Lymph node
Lymph node metastasis of E08
F09
M
73
Lymph node
Lymph node metastasis of E09
F10
M
57
Lymph node
Lymph node metastasis of E10
F11
F
31
Lymph node
Lymph node metastasis of E11
F12
M
54
Lymph node
Lymph node metastasis of E12
G01
M
62
Stomach
Adenocarcinoma
III
T3N2M0
G02
F
64
Stomach
Adenocarcinoma
III
T3N2M0
G03
M
51
Stomach
Signet ring cell carcinoma
T3N2M0
G04
M
61
Stomach
Adenocarcinoma
III
T3N1M0
G05
F
57
Stomach
Adenocarcinoma
III
T3N2M0
G06
M
60
Stomach
Adenocarcinoma
II
T3N1M0
G07
F
40
Stomach
Adenocarcinoma
III
T3N2M0
G08
M
57
Stomach
Adenocarcinoma
II
T3N2M0
G09
M
64
Stomach
Adenocarcinoma
II
T4N1M0
G10
M
47
Stomach
Adenocarcinoma
III
T1N2M0
G11
F
68
Stomach
Signet ring cell carcinoma
T3N1M0
G12
M
60
Stomach
Muncinous adenocarcinoma
T3N2M0
H01
M
62
Lymph node
Lymph node metastasis of G01
H02
F
64
Lymph node
Lymph node metastasis of G02
H03
M
51
Lymph node
Lymph node metastasis of G03
H04
M
61
Lymph node
Lymph node metastasis of G04
H05
F
57
Lymph node
Lymph node metastasis of G05
H06
M
60
Lymph node
Lymph node metastasis of G06
H07
F
40
Lymph node
Lymph node metastasis of G07
H08
M
57
Lymph node
Lymph node metastasis of G08
H09
M
64
Lymph node
Lymph node metastasis of G09
H10
M
47
Lymph node
Lymph node metastasis of G10
H11
F
68
Lymph node
Lymph node metastasis of G11
H12
M
60
Lymph node
Lymph node metastasis of G12
null

Download Data Sheet

bottom of page